Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516952
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-18
Brief Title:
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 3 Randomized Double-Blind Placebo-Controlled Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STOP-PN1
Brief Summary:
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None